GlassScriptPhysician profile
Glen S Graves
NPI 1689648040
$2,171.30
in general payments reported to CMS, 2019-2025
19 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $81.46 · 2021: $252 · 2022: $307 · 2023: $320 · 2024: $430 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $739.61 | 2019-2025 | |
| Amgen INC. | $255.44 | 2021-2025 | Otezla, Enbrel, Tavneos |
| Pfizer INC. | $188.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $140.93 | 2023-2025 | |
| Glaxosmithkline, LLC. | $114.69 | 2019-2024 | Benlysta |
| Janssen Biotech, INC. | $111.12 | 2019-2022 | |
| Genentech USA, INC. | $110.23 | 2019-2025 | Gazyva, Actemra, Rituxan |
| Horizon Therapeutics Plc | $101.45 | 2021-2023 | Krystexxa |
| Lilly USA, LLC | $73.78 | 2019-2024 | Taltz |
| Astrazeneca Pharmaceuticals LP | $61.71 | 2022-2025 | Saphnelo |
| Fresenius Kabi USA, LLC | $47.44 | 2024 | Idacio |
| Depuy Synthes Sales INC. | $43.66 | 2021-2025 | Monovisc, Orthovisc |
| Aurinia Pharma U.S., INC. | $37.36 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $32.70 | 2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $29.61 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $26.47 | 2023 | Acthar |
| Celgene Corporation | $26.17 | 2019 | |
| Pacira Therapeutics, INC. | $17.01 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.